Patent directory · USPTO A61K / A61P
Patents matching “cells”
914 pharma patents match "cells" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 914 pharmaceutical patents matching "cells" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11173318
Method of repairing age and disease immune dysfunction and cellular senescence with lymphoid stem cells and then re-applying those for therapeutic use
granted -
US 11173173
Methods for treating chemoresistant cancer-initiating cells
granted -
US 11166985
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 11161908
BAFF-R targeted chimeric antigen receptor-modified t-cells and uses thereof
granted -
US 11162079
Blood type O Rh-hypo-immunogenic pluripotent cells
granted -
US 11154572
Methods of treatment with natural killer cells matched for killer immunoglobulin receptor type
granted -
US 11154573
Methods of generating T-cells from stem cells and immunotherapeutic methods using the T-cells
granted -
US 11154639
Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same
granted -
US 11147837
Modified cells and methods of therapy
granted -
US 11147883
Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells
granted -
US 11149251
Methods for preparing therapeutically active cells using microfluidics
granted -
US 11149253
Small molecule compound combination for reprogramming digestive tract derived epithelial cells to endodermal stem/progenitor cells, reprogramming method and application
granted -
US 11142583
BCMA-CAR-natural killer (NK) cells and methods related thereto
granted -
US 11141393
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
granted -
US 11142746
High efficiency microfluidic purification of stem cells to improve transplants
granted -
US 11135247
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted -
US 11130999
Cas-ready mouse embryonic stem cells and mice and uses thereof
granted -
US 11124768
Optimally activated dendritic cells that induce an improved or increased anti-tumor immune response
granted -
US 11118195
Universal donor cells
granted -
US 11118170
Engineered clostridium botulinum toxin adapted to deliver molecules into selected cells
granted -
US 11116798
Universal donor cells
granted -
US 11118196
Universal donor cells
granted -
US 11116797
Universal donor cells
granted -
US 11104918
Universal donor cells
granted